Skip to content

Corporate Responsibility

We go beyond our treatments to support and champion our teams, our patients and our communities, to build a better world.

Read Our 2025 Corporate Responsibility Report

A Personal Mission

At Acadia, our Corporate Responsibility approach is rooted in our mission to transform scientific promise into meaningful innovation for people living with neurological disorders and rare diseases. We believe advancing care for underserved communities goes hand in hand with responsible business practices, ethical leadership and a commitment to sustainability.

Our 2025 Corporate Responsibility Report provides transparency into our priorities and progress across our people, communities, products, environment and governance.

Ensuring Drug Safety and Quality

Our dedication to patients guides how we research, develop, manufacture and deliver safe, effective and innovative therapies. We maintain a comprehensive Quality Management System designed to support safety, efficacy, regulatory compliance and continuous improvement.

  • Policy: Our quality policies are designed to align with FDA regulations, ICH guidelines, GCP, GVP, GMP requirements and applicable international and local standards.
  • Management: Cross-functional teams conduct routine audits, documentation reviews, vendor assessments and product evaluations to support regulatory compliance and operational excellence.
  • Drug Safety: Our pharmacovigilance system supports ongoing safety monitoring through clinical development and post-marketing surveillance, with processes for adverse event reporting, signal evaluation and timely follow-up.
Acadia scientists reviewing data

Supporting Our Community

Access to Medicine and Support

Ensuring patients can access the treatments they need is central to Acadia’s mission. Through advocacy, partnerships and dedicated support platforms, we work to help address barriers to care for people living with neurological and rare diseases.

  • Access Programs: Where appropriate and in accordance with applicable laws and regulations, Acadia supports programs that help eligible patients access therapies and provides donations to independent, nonprofit charitable foundations that support patient assistance.
  • Acadia Connect: Acadia Connect helps patients and caregivers navigate prescriptions, insurance coverage and financial assistance, with support from dedicated Care Coordinators.
Acadia Connect logo

Charitable Giving and Partnerships

Acadia’s community engagement spans partnerships, employee volunteerism, patient advocacy and targeted philanthropy. We collaborate with organizations such as Fleet Science Center, YMCA, The Michael J. Fox Foundation, Red Cross, United Way, and Project Onramp to support patients, families and the communities where we live and work.

Acadians also give back through volunteer opportunities, including one paid volunteer day each year, and through company-supported service projects and patient advocacy events.

Elderly couple smiling and embracing each other outdoors, conveying love and companionship in a joyful moment

Keeping Our Planet Healthy

Environmental stewardship is part of how we operate responsibly. We are embedding environmental responsibility into our business strategy and daily operations, with a focus on regulatory compliance, climate risk management, emissions measurement, data quality and continuous improvement.

Acadia is building the systems and processes needed for greenhouse gas emissions reporting in accordance with California Senate Bill 253, including disclosure of Scope 1 and Scope 2 emissions with plans to expand to Scope 3, and evaluating opportunities to reduce energy use, improve building efficiency and minimize waste.

Grandfather giving granddaughter a piggy back ride

Corporate Governance

Strong governance and ethical leadership help ensure we operate responsibly as we grow. Our Corporate Responsibility approach includes Board and management oversight of key risks and opportunities, enterprise risk management, compliance, data privacy, cybersecurity and a Code of Conduct that applies to all employees, officers and directors.

Compliance

Led by our Chief Compliance Officer, our compliance program supports adherence to applicable laws, regulations and industry standards through written policies, training, monitoring, auditing and oversight. We encourage reporting of potential issues and maintain protections against retaliation for those who report concerns in good faith.

Code of Conduct

Our Code of Conduct embodies the principles and practices that define how we conduct our work and applies to all employees, officers and directors. It guides ethical business conduct, reinforces expectations for integrity and sound judgment, and supports a culture where Acadians can raise questions or report concerns without fear of retaliation.

Clinical Trial Participants

Patients make our clinical trials possible. We conduct studies with a commitment to participant safety, scientific integrity, data privacy and high-quality evidence, while working to support diverse participation and reduce logistical barriers where appropriate.

Important Note

You are now being redirected

You are now leaving acadia.com

You are about to leave acadia.com. You will be redirected to a third party website not affiliated with Acadia Pharmaceuticals Inc.
Do you want to continue?

You are leaving our {{LEAVING_REGION}} website and going to our {{ENTERING_REGION}} website, which is in {{ENTERING_LANGUAGE}}.
The information you are about to be referred to may not comply with the local regulatory requirements.
Do you want to continue?

You are now being directed to another Acadia website that contains information about specific treatment(s).
Do you want to continue?

Continue